CA Stock MarketDetailed Quotes

EVMT Evome Medical Technologies Inc

Watchlist
  • 0.095
  • 0.0000.00%
15min DelayMarket Closed Dec 13 16:00 ET
7.86MMarket Cap-0.32P/E (TTM)

Evome Medical Technologies Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Feb 28, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1,787.91%1.79M
384.68%3.12M
25.71%-612.11K
-11.04%-918.91K
146.78%1.11M
-105.81K
-1.1M
-823.9K
74.76%-827.56K
28.33%-2.37M
Net income from continuing operations
-138.46%-1.15M
-104.68%-2.28M
-157.77%-4.29M
1.85%-15.6M
-1,276.52%-15.81M
--2.99M
---1.12M
---1.66M
-282.06%-15.9M
67.50%-1.15M
Operating gains losses
-39,022.98%-990.98K
--4.81M
--571.19K
--25.67K
--0
--2.55K
----
----
----
5.47%-902.87K
Depreciation and amortization
52.54%1.81M
-69.88%348.16K
-47.13%484.59K
108.69%2.48M
-314.90%-772.18K
--1.18M
--1.16M
--916.64K
88.57%1.19M
--359.31K
Asset impairment expenditure
--0
--5.25K
--708.94K
--13.51M
--13.51M
--0
--0
--0
--0
----
Remuneration paid in stock
---32.59K
---83.4K
--910
--690.8K
----
----
----
----
--0
----
Unrealized gains and losses of investment securities
----
----
----
----
----
----
----
----
----
99.98%-32
Remuneration paid in stock
-72.65%72.38K
-65.13%136.56K
-170.95%-245.16K
0.75%1.29M
-34.62%286.72K
--264.64K
--391.57K
--345.52K
41.48%1.28M
-58.64%438.57K
Deferred tax
----
----
----
----
----
--0
----
----
----
----
Other non cashItems
100.41%15.6K
170.01%641.14K
-17.87%246.36K
-117.62%-2.39M
135.21%2.04M
---3.82M
---915.75K
--299.96K
16,166.89%13.59M
---5.8M
Change In working capital
383.93%2.06M
28.46%-455K
363.67%1.91M
6.35%-924.9K
260.46%1.16M
---726.9K
---635.96K
---723.29K
-753.24%-987.6K
-177.81%-723.68K
-Change in receivables
1.66%1.15M
84.61%-492.01K
157.26%653.96K
-25.60%-1.9M
230.12%1.3M
--1.14M
---3.2M
---1.14M
4.42%-1.51M
---1M
-Change in inventory
-13.46%1.05M
-55.06%294.56K
-131.88%-437.19K
360.62%4.65M
974.64%1.4M
--1.22M
--655.43K
--1.37M
-1,104.74%-1.78M
---160.43K
-Change in prepaid assets
341.65%350.66K
72.45%-375.9K
-717.46%-192.95K
-2,900.07%-1.1M
284.31%383.35K
---145.11K
---1.36M
--31.25K
-109.39%-36.51K
-390.39%-208K
-Change in payables and accrued expense
-24.36%-223.08K
-82.57%505.17K
31.05%-353.8K
-151.76%-972.45K
-593.74%-3.18M
---179.39K
--2.9M
---513.09K
172.45%1.88M
-59.43%643.64K
-Change in other current liabilities
90.17%-270.68K
-204.03%-386.81K
575.14%2.24M
-443.17%-1.6M
95,849.39%1.25M
---2.75M
--371.83K
---470.83K
-2.65%466.83K
--1.3K
Cash from discontinued investing activities
Operating cash flow
1,787.91%1.79M
384.68%3.12M
25.71%-612.11K
-11.04%-918.91K
146.78%1.11M
---105.81K
---1.1M
---823.9K
75.00%-827.56K
28.33%-2.37M
Investing cash flow
Cash flow from continuing investing activities
76.39%-21.61K
100.00%-1
58.78%-38.43K
72.86%-1.52M
105.04%23.96K
-91.52K
-1.36M
-93.23K
-21.48%-5.6M
89.89%-475.27K
Net PPE purchase and sale
76.39%-21.61K
100.00%-1
58.78%-38.43K
68.21%-203.27K
268.64%23.96K
---91.52K
---42.48K
---93.23K
-1,313.29%-639.47K
---14.21K
Net intangibles purchas and sale
----
----
----
--0
--0
--0
----
----
---243.2K
----
Net business purchase and sale
----
----
----
72.09%-1.32M
--0
--0
---1.32M
--0
6.81%-4.71M
---245.75K
Net investment purchase and sale
----
----
----
----
----
----
----
----
----
--0
Cash from discontinued investing activities
Investing cash flow
76.39%-21.61K
100.00%-1
58.78%-38.43K
72.86%-1.52M
105.04%23.96K
---91.52K
---1.36M
---93.23K
-21.48%-5.6M
89.89%-475.27K
Financing cash flow
Cash flow from continuing financing activities
-8,576.22%-1.67M
-1,035.29%-2.61M
-109.89%-255.03K
112.46%824.54K
-130.69%-1.54M
19.67K
-229.88K
2.58M
158.92%388.09K
27.93%5.03M
Net issuance payments of debt
-8,576.22%-1.67M
-1,035.29%-2.61M
-110.03%-255.03K
196.52%790.64K
-218.64%-1.54M
--19.67K
---229.88K
--2.54M
-118.13%-819.14K
--1.3M
Net common stock issuance
----
----
----
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--0
--0
--0
-84.68%33.9K
--0
--0
--0
--33.9K
-41.29%221.28K
-100.00%-1
Net other financing activities
----
----
----
----
----
----
----
----
249.37%985.95K
---535.17K
Cash from discontinued financing activities
Financing cash flow
-8,576.22%-1.67M
-1,035.29%-2.61M
-109.89%-255.03K
112.46%824.54K
-130.69%-1.54M
--19.67K
---229.88K
--2.58M
158.92%388.09K
27.93%5.03M
Net cash flow
Beginning cash position
-23.19%1.07M
-93.72%232.17K
-52.36%918.68K
-76.07%1.93M
-82.82%1.05M
--1.4M
--3.7M
--1.93M
-35.57%8.06M
-20.98%6.13M
Current changes in cash
154.54%96.89K
119.11%513K
-154.54%-905.57K
73.28%-1.61M
-118.82%-411.13K
---177.66K
---2.68M
--1.66M
29.61%-6.04M
153.62%2.18M
Effect of exchange rate changes
244.48%242.44K
-14.90%328.69K
103.16%219.06K
755.48%603.43K
208.81%277.16K
---167.8K
--386.26K
--107.82K
-117.16%-92.06K
-216.39%-254.73K
End cash Position
34.25%1.41M
-23.19%1.07M
-93.72%232.17K
-52.36%918.68K
-88.60%918.68K
--1.05M
--1.4M
--3.7M
-56.82%1.93M
0.00%8.06M
Free cash from
994.12%1.76M
374.07%3.12M
29.07%-650.54K
34.38%-1.12M
147.51%1.13M
---197.33K
---1.14M
---917.14K
49.03%-1.71M
29.08%-2.38M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Feb 28, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1,787.91%1.79M384.68%3.12M25.71%-612.11K-11.04%-918.91K146.78%1.11M-105.81K-1.1M-823.9K74.76%-827.56K28.33%-2.37M
Net income from continuing operations -138.46%-1.15M-104.68%-2.28M-157.77%-4.29M1.85%-15.6M-1,276.52%-15.81M--2.99M---1.12M---1.66M-282.06%-15.9M67.50%-1.15M
Operating gains losses -39,022.98%-990.98K--4.81M--571.19K--25.67K--0--2.55K------------5.47%-902.87K
Depreciation and amortization 52.54%1.81M-69.88%348.16K-47.13%484.59K108.69%2.48M-314.90%-772.18K--1.18M--1.16M--916.64K88.57%1.19M--359.31K
Asset impairment expenditure --0--5.25K--708.94K--13.51M--13.51M--0--0--0--0----
Remuneration paid in stock ---32.59K---83.4K--910--690.8K------------------0----
Unrealized gains and losses of investment securities ------------------------------------99.98%-32
Remuneration paid in stock -72.65%72.38K-65.13%136.56K-170.95%-245.16K0.75%1.29M-34.62%286.72K--264.64K--391.57K--345.52K41.48%1.28M-58.64%438.57K
Deferred tax ----------------------0----------------
Other non cashItems 100.41%15.6K170.01%641.14K-17.87%246.36K-117.62%-2.39M135.21%2.04M---3.82M---915.75K--299.96K16,166.89%13.59M---5.8M
Change In working capital 383.93%2.06M28.46%-455K363.67%1.91M6.35%-924.9K260.46%1.16M---726.9K---635.96K---723.29K-753.24%-987.6K-177.81%-723.68K
-Change in receivables 1.66%1.15M84.61%-492.01K157.26%653.96K-25.60%-1.9M230.12%1.3M--1.14M---3.2M---1.14M4.42%-1.51M---1M
-Change in inventory -13.46%1.05M-55.06%294.56K-131.88%-437.19K360.62%4.65M974.64%1.4M--1.22M--655.43K--1.37M-1,104.74%-1.78M---160.43K
-Change in prepaid assets 341.65%350.66K72.45%-375.9K-717.46%-192.95K-2,900.07%-1.1M284.31%383.35K---145.11K---1.36M--31.25K-109.39%-36.51K-390.39%-208K
-Change in payables and accrued expense -24.36%-223.08K-82.57%505.17K31.05%-353.8K-151.76%-972.45K-593.74%-3.18M---179.39K--2.9M---513.09K172.45%1.88M-59.43%643.64K
-Change in other current liabilities 90.17%-270.68K-204.03%-386.81K575.14%2.24M-443.17%-1.6M95,849.39%1.25M---2.75M--371.83K---470.83K-2.65%466.83K--1.3K
Cash from discontinued investing activities
Operating cash flow 1,787.91%1.79M384.68%3.12M25.71%-612.11K-11.04%-918.91K146.78%1.11M---105.81K---1.1M---823.9K75.00%-827.56K28.33%-2.37M
Investing cash flow
Cash flow from continuing investing activities 76.39%-21.61K100.00%-158.78%-38.43K72.86%-1.52M105.04%23.96K-91.52K-1.36M-93.23K-21.48%-5.6M89.89%-475.27K
Net PPE purchase and sale 76.39%-21.61K100.00%-158.78%-38.43K68.21%-203.27K268.64%23.96K---91.52K---42.48K---93.23K-1,313.29%-639.47K---14.21K
Net intangibles purchas and sale --------------0--0--0-----------243.2K----
Net business purchase and sale ------------72.09%-1.32M--0--0---1.32M--06.81%-4.71M---245.75K
Net investment purchase and sale --------------------------------------0
Cash from discontinued investing activities
Investing cash flow 76.39%-21.61K100.00%-158.78%-38.43K72.86%-1.52M105.04%23.96K---91.52K---1.36M---93.23K-21.48%-5.6M89.89%-475.27K
Financing cash flow
Cash flow from continuing financing activities -8,576.22%-1.67M-1,035.29%-2.61M-109.89%-255.03K112.46%824.54K-130.69%-1.54M19.67K-229.88K2.58M158.92%388.09K27.93%5.03M
Net issuance payments of debt -8,576.22%-1.67M-1,035.29%-2.61M-110.03%-255.03K196.52%790.64K-218.64%-1.54M--19.67K---229.88K--2.54M-118.13%-819.14K--1.3M
Net common stock issuance ----------------------0--0--0--------
Proceeds from stock option exercised by employees --0--0--0-84.68%33.9K--0--0--0--33.9K-41.29%221.28K-100.00%-1
Net other financing activities --------------------------------249.37%985.95K---535.17K
Cash from discontinued financing activities
Financing cash flow -8,576.22%-1.67M-1,035.29%-2.61M-109.89%-255.03K112.46%824.54K-130.69%-1.54M--19.67K---229.88K--2.58M158.92%388.09K27.93%5.03M
Net cash flow
Beginning cash position -23.19%1.07M-93.72%232.17K-52.36%918.68K-76.07%1.93M-82.82%1.05M--1.4M--3.7M--1.93M-35.57%8.06M-20.98%6.13M
Current changes in cash 154.54%96.89K119.11%513K-154.54%-905.57K73.28%-1.61M-118.82%-411.13K---177.66K---2.68M--1.66M29.61%-6.04M153.62%2.18M
Effect of exchange rate changes 244.48%242.44K-14.90%328.69K103.16%219.06K755.48%603.43K208.81%277.16K---167.8K--386.26K--107.82K-117.16%-92.06K-216.39%-254.73K
End cash Position 34.25%1.41M-23.19%1.07M-93.72%232.17K-52.36%918.68K-88.60%918.68K--1.05M--1.4M--3.7M-56.82%1.93M0.00%8.06M
Free cash from 994.12%1.76M374.07%3.12M29.07%-650.54K34.38%-1.12M147.51%1.13M---197.33K---1.14M---917.14K49.03%-1.71M29.08%-2.38M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.